← FDA Drug Approvals (Drugs@FDA)

CARBOPROST TROMETHAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2026-05-27

Drug application

FDA Application #
ANDA219529
Application type
Abbreviated New Drug Application (Generic)
Brand name
CARBOPROST TROMETHAMINE
Generic name
CARBOPROST TROMETHAMINE
Active ingredients
CARBOPROST TROMETHAMINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SOMERSET THERAPS LLC
Manufacturer
Somerset Therapeutics, LLC
First approval
2026-05-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown